Akcea Therapeutics, Inc. EBITDA 2017-2020 | AKCA
Akcea Therapeutics, Inc. ebitda from 2017 to 2020. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
| Akcea Therapeutics, Inc. Annual EBITDA (Millions of US $) |
|
|---|---|
| 2019 | $45 |
| 2018 | $-228 |
| 2017 | $-120 |
| 2016 | $-83 |
| 2015 | $-61 |
| 2014 | $-30 |
| Akcea Therapeutics, Inc. Quarterly EBITDA (Millions of US $) |
|
|---|---|
| 2020-06-30 | $-49 |
| 2020-03-31 | $-43 |
| 2019-12-31 | $85 |
| 2019-09-30 | $-31 |
| 2019-06-30 | $-37 |
| 2019-03-31 | $28 |
| 2018-12-31 | $-70 |
| 2018-09-30 | $-64 |
| 2018-06-30 | $-63 |
| 2018-03-31 | $-30 |
| 2017-12-31 | $-21 |
| 2017-09-30 | $-16 |
| 2017-06-30 | $-20 |
| 2017-03-31 | $-63 |
| 2016-09-30 | $-20 |
| 2016-06-30 | $-14 |
